Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics
Introduction: Intranasal influenza vaccines are expected to confer protection among vaccine recipients by successful induction of mucosal immune response in the upper respiratory tract. Though only live attenuated influenza virus vaccines (LAIVs) are licensed and available for intranasal use in huma...
Saved in:
Main Authors: | Kaori Sano (Author), Akira Ainai (Author), Tadaki Suzuki (Author), Hideki Hasegawa (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration
by: Yoshihiko Terauchi, et al.
Published: (2018) -
Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines
by: Edward W. Thommes, et al.
Published: (2017) -
Seasonal Influenza Epidemics and El Ninos
by: Olusegun Steven Ayodele Oluwole
Published: (2015) -
Effectiveness of seasonal inactivated influenza vaccination in Japanese schoolchildren: an epidemiologic study at the community level
by: Yasutaka Kuniyoshi, et al.
Published: (2020) -
Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?
by: Yong Chong, et al.
Published: (2018)